Anticoccidial Drugs Market Report 2025

This Anticoccidial Drugs market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals.

The anticoccidial drugs market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the growing number of veterinary healthcare, the rising prevalence of coccidiosis in animals, the increasing use of synthetic drugs, the growing demand for feed additives, and increasing livestock production. Major trends in the forecast period include the surge in demand driven by emerging coccidiosis strains, a shift towards natural and alternative treatment methods, increased regulatory scrutiny prompting innovation, rising consumer preferences for antibiotic-free poultry products, advancements in drug delivery technologies, heightened focus on preventive healthcare measures, and expanding applications in aquaculture and companion animal sectors.

The increasing demand for meat proteins is expected to drive the growth of the anticoccidial drug market in the coming years. Meat proteins, which are naturally found in animal flesh, consist of various essential amino acids that play a crucial role in bodily functions. This rising demand for meat proteins is driven by factors such as population growth, higher disposable income, urbanization, and changing dietary preferences toward protein-rich foods. Anticoccidial drugs are critical in modern livestock farming, as they help maintain animal health and productivity, allowing farmers to meet the growing demand for meat proteins in a sustainable and efficient manner. For example, a report published in July 2023 by the Organization for Economic Co-operation and Development (OECD) and the Food and Agriculture Organization (FAO) noted that while global average per capita meat demand is expected to rise by 2% from the 2020-2022 base period to 2032, the FAO meat price index increased by 10% in 2022 due to lower export supplies. As a result, the growing demand for meat proteins is fueling the expansion of the anticoccidial drug market.

The upsurge in poultry farming is poised to drive the advancement of the anticoccidial drug market in the coming years. Poultry farming involves the rearing of domesticated avian species such as chickens, turkeys, ducks, and geese for the production of meat, eggs, and feathers. This increase in poultry farming is attributed to a growing demand for protein, enhancements in farming methodologies, and the expansion of global trade. Anticoccidial drugs are commonly administered to poultry either through feed or water as a preemptive measure to shield the birds from coccidiosis during their initial and most susceptible growth stages. For instance, as reported by the USDA Economic Research Service in June 2023, total sales in the poultry sector soared to $76.9 billion in 2022, marking a notable 67% surge from the preceding year. Hence, the surge in poultry farming acts as a catalyst for the burgeoning growth of the anticoccidial drug market.

Leading companies in the anticoccidial drugs market are focusing on developing innovative solutions, such as synthetic coccidiostats, to improve efficacy, reduce resistance development, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound used to prevent or control coccidiosis by inhibiting the growth and reproduction of coccidia parasites in animals. For example, in March 2023, Zoetis, a US-based animal health company, introduced Avi-Deccox, a reformulated synthetic coccidiostat designed to control coccidiosis in broiler chickens. This product targets the pathogens Eimeria acervulina and Eimeria tenella, which cause significant economic losses in poultry farming. Featuring decoquinate as its active ingredient, similar to its predecessor, Deccox, Avi-Deccox addresses the growing issue of resistance linked to the frequent use of ionophores in poultry farming by utilizing a different mode of action, offering a more effective short-term knockdown effect.

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc, Bayer AG, Novartis AG, Eli Lilly and Company Ltd, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc, Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd.

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the anticoccidial drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Anticoccidial drugs constitute a category of medications employed in the prevention and treatment of coccidiosis, an intestinal parasitic ailment induced by protozoa from the genus Eimeria. These medications function by impeding diverse stages of the coccidia life cycle, thereby managing the infection and averting the consequential intestinal harm and associated symptoms. Widely utilized in veterinary practice, especially in poultry, these drugs contribute to bolstering health and productivity by addressing this prevalent and economically impactful condition.

The primary categories of anticoccidial drugs encompass ionophores, antibiotics, sulphonamides, chemical derivatives, and others. Ionophores, for instance, intervene in the proliferation and propagation of coccidia parasites by modulating ion movement across cellular membranes. These drugs exhibit varied actions, serving both coccidiostatic and coccidiocidal purposes across diverse applications such as poultry, swine, fish, cattle, and companion animals. They are distributed through various channels, including veterinary hospitals, retail pharmacies, among others.

The anticoccidial drugs market research report is one of a series of new reports that provides anticoccidial drugs market statistics, including anticoccidial drugs industry global market size, regional shares, competitors with a anticoccidial drugs market share, detailed anticoccidial drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anticoccidial drugs industry. This anticoccidial drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anticoccidial drugs market consist of sales of monensin, semduramicin, lasalocid, decoquinate, salinomycin, amprolium, clopidol, and sulfachloropyrazine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.